Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Pfizer Inc

(NYSE: PFE)
Add to Portfolio
+0.46 (+1.63%)
as of May 31, 2024

Values in US Thousands
  12-2023 12-2022 12-2021 12-2020
Sales $ 58,496,000 $ 100,330,000 $ 81,288,000 $ 41,651,000
Cost of Goods 24,954,000 34,344,000 30,821,000 8,484,000
Gross Profit 33,542,000 65,986,000 50,467,000 33,167,000
Operating Expenses 33,320,000 31,042,000 31,034,000 24,917,000
Operating Income 222,000 34,944,000 19,433,000 8,250,000
Other Income/Expenses 836,000 -215,000 4,878,000 -1,214,000
Pre-tax Income 1,058,000 34,729,000 24,311,000 7,036,000
Income Taxes -1,115,000 3,328,000 1,852,000 370,000
Net Income from Cont. Operations 2,172,000 31,401,000 22,459,000 6,666,000
Net Income from Discont. Operations -15,000 6,000 -434,000 2,529,000
Minority Interest 39,000 35,000 45,000 36,000
Total Net Income $ 2,119,000 $ 31,372,000 $ 21,980,000 $ 9,159,000
Basic EPS from Cont. Ops. 0.38 5.59 4.00 1.19
Basic EPS from Discont. Operations - - -0.08 0.46
Basic EPS from Total Ops. 0.38 5.59 3.92 1.65
Diluted EPS from Cont. Ops 0.37 5.47 3.93 1.18
Diluted EPS from Discont. Operations - - -0.08 0.45
Diluted EPS from Total Operations 0.37 5.47 3.85 1.63
EBITDA 6,512,000 40,008,000 24,624,000 12,931,000